The German consortium composed by BioMcon, Inova DE GmbH and The Pathology Department of the University of Göttingen joined to develop the AMUI project, aiming to improve the method of how oncologic diseases are diagnosed and treated.

The main objective of this project is to integrate AutoMax into the pathologist’s workflow. With the rise of targeted drugs in oncology, pathology institutions are facing novel challenges: targeted drugs require specific aberrations of cancer-cells and new diagnostic methods to identify eligible tumours. Image-based molecular pathology extracts and quantifies specific features from these images, as to define which biomarkers have positive detection and consequently aid the treatment decision. Typically, this task is carried out by viewing on a microscope with manual steps for documenting the obtained quantifications – a tedious and failure-prone process. Automax transform this standard by automating and enabling advanced image analysis methods and represents a valuable support tool for the responsible pathologist, as it helps on the diagnosis process.

The project will run until the end of February 2018.

Do you want to know how much we can do for you and your project?